Glycopyrrolate 0.4mg/mL IV Premix Bag from Canada
Ready-to-use IV premix bag containing glycopyrrolate for hospital administration to control gastric motility. As a dissolved unmixed product per notes, in measured doses for digestive therapeutic uses under HTS 3004.90.92.57.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Comply with USP <797> for non-hazardous sterile preps
• Label with barcodes for hospital systems integration
• Ensure overfill declarations match actual volume